Overview

Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Goal: To characterize the cellular events that occur in vivo after vaccination with an emulsion of GMCSF-in-adjuvant. Design: Open-label, single dose study in two stages.

Phase:

N/A

Details

Lead Sponsor:

University of Virginia

Treatments:

Freund's Adjuvant
Molgramostim
Sargramostim